Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Karin Barchan"'
Autor:
Peter Ellmark, Karin Hägerbrand, Mia Thagesson, Doreen Werchau, Anna Rosén, Karin Barchan, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Barnabas Nyesiga, Eva Lindqvist
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
Autor:
Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand, Anna Dahlman, Karin Enell Smith, Sara Fritzell, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Maria Johansson, Anna Rosén, Ida Åberg, Magnus Winnerstam, Eva Nyblom, Karin Barchan, Christina Furebring, Per Norlén, Peter Ellmark
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background The CTLA-4 blocking antibody ipilimumab has demonstrated substantial and durable effects in patients with melanoma. While CTLA-4 therapy, both as monotherapy and in combination with PD-1 targeting therapies, has great potential in
Externí odkaz:
https://doaj.org/article/ac146a36143540ed83d59ae4ac9773f4
Autor:
Peter Ellmark, Karin Hägerbrand, Doreen Werchau, Anna Rosén, Karin Barchan, Adnan Deronic, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Lill Ljug, Mia Thageson, Christina Sakellariou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bc293d52dd564f1e929282860de5f171
Autor:
Barnabas Nyesiga, Mia Thagesson, Anna Rosén, Karin Hägerbrand, Mattias Levin, Karin Barchan, Laura Varas, Anette Sundstedt, Anna Säll, Doreen Werchau, Peter Ellmark, Lill Ljung, Laura Von Schantz, Eva Lindqvist, Adnan Deronic
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAlligator's Neo-X-Prime platform aims to enable antigen presenting cells to efficiently enhance priming of tumor neoantigen-specific T cells with the goal of overcoming PD-1 resistance in certain tumor types. We hypothesize that binding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254b3a98cca7dddc470b999478d652d6
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
https://doaj.org/article/9e6a3658910c424b887736939f0b115c
Autor:
Sara Fritzell, Anne Månsson Kvarnhammar, Karin Enell Smith, Laura Von Schantz, Mia Thagesson, Doreen Werchau, Anna Rosén, Per Norlén, Karin Hägerbrand, Eva Nyblom, Peter Ellmark, Niina Veitonmäki, Christina Furebring, Kristine Smedenfors, Maria Johansson, Karin Barchan, Magnus Winnerstam, Ida Åberg, Anna Dahlman
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Background The CTLA-4 blocking antibody ipilimumab has demonstrated substantial and durable effects in patients with melanoma. While CTLA-4 therapy, both as monotherapy and in combination with PD-1 targeting therapies, has great potential in many ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09cbba20b753513ce8ee3f014583fcfc
http://europepmc.org/articles/PMC6458634
http://europepmc.org/articles/PMC6458634
Autor:
Anna Rosén, Anna Dahlman, Karin Enell Smith, Karin Barchan, Peter Ellmark, Tina Furebring, Eva Dahlén
Publikováno v:
Cancer Immunology Research. 7:A183-A183
4-1BB (CD137) is an inducible co-stimulatory receptor expressed on activated T-cells and natural killer (NK) cells. Activation of 4-1BB induces proliferation, cytokine production, cytotoxic function and survival of T and NK cells. Most importantly, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a8ed1f0d6684ce81245c6c3e80df6cc
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a183
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a183
Autor:
Cecilia Forsberg, Erika Gustafsson, Karin Barchan, Kok P. M. van Kessel, Karin Haraldsson, Anna Rosén, Christina Furebring, Pieter-Jan A. Haas, Jos A. G. van Strijp, Björn Walse, Lill Ljung, Stina Lindman, Karin Bryder
Publikováno v:
Protein Engineering, Design and Selection. 23:91-101
Chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) is a protein that binds and blocks the C5a receptor (C5aR) and formylated peptide receptor, thereby inhibiting the immune cell recruitment associated with inflammation. If CHIPS was less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2aaf13f755a792701210d93349843a9
https://doi.org/10.1093/protein/gzp062
https://doi.org/10.1093/protein/gzp062
Autor:
Wim B. van den Berg, Patrik Höjman, Björn Walse, Lill Ljung, Leo A. B. Joosten, Marie Karlsson, Daniel Herrlander, Ann-Christin Malmborg Hager, Eva Bäckman, Karin Barchan, Mats Andersson, Eva Dahlén
Publikováno v:
Journal of Immunotoxicology, 5, 189-99
Journal of Immunotoxicology, 5, 2, pp. 189-99
Journal of Immunotoxicology, 5, 2, pp. 189-99
Item does not contain fulltext Interleukin-1 receptor antagonist (IL-1Ra) is a naturally occurring inhibitor of the pro-inflammatory interleukin-1-mediated activation of the interleukin-1 receptor (IL-1R). Although wild-type IL-1Ra is used for treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95365b9952bbbe632daa1f09b67927e8
https://doi.org/10.1080/15476910802131477
https://doi.org/10.1080/15476910802131477
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 80:1084-1090
Background. During pregnancy and parturition a remodeling within the extracellular matrix of the cervix and the corpus uteri occurs, which is of fundamental importance to a normal labor. The aim of this study is to identify the major proteoglycans in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcffb1dd597107cf6981d44a500a7d55
https://doi.org/10.1034/j.1600-0412.2001.801202.x
https://doi.org/10.1034/j.1600-0412.2001.801202.x
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology. 100(2)
Objective: To characterise uterine proteoglycans and changes therein during pregnancy and labour. Study Design: Uterine samples were collected from 6 non-pregnant, 10 term-pregnant and from 10 women in active tabour. The proteoglycans were extracted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33dac3bca187f6869ebde552ffc97eb1
https://pubmed.ncbi.nlm.nih.gov/11750954
https://pubmed.ncbi.nlm.nih.gov/11750954